Ilyang Pharmaceutical Co.,Ltd Total Liabilities

Latest as of June 2026: ₩194.78 Billion KRW ≈ $132.00 Million USD

Ilyang Pharmaceutical Co.,Ltd total liabilities. Based on the latest financial reports, Ilyang Pharmaceutical Co.,Ltd (007575) has total liabilities worth ₩194.78 Billion KRW (≈ $132.00 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 007575 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Ilyang Pharmaceutical Co.,Ltd (2014–2025)

Total liabilities of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025. This chart illustrates how Ilyang Pharmaceutical Co.,Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Ilyang Pharmaceutical Co.,Ltd to see how much of total assets are deployed in long-term investments.

Ilyang Pharmaceutical Co.,Ltd Competitors by Total Liabilities

The table below lists competitors of Ilyang Pharmaceutical Co.,Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Immutep Ltd ADR NASDAQ:IMMP	USA	$48.30 Million
Phenixfin Corporation NASDAQ:PFX	USA	$152.02 Billion
Nova Minerals Limited NYSE MKT:NVA	USA	$1.06 Billion
Byrna Technologies Inc NASDAQ:BYRN	USA	$11.43 Million
Zuari Agro Chemicals Limited NSE:ZUARI	India	Rs15.46 Billion
Compagnie Industrielle et Financière d'Entreprises SA PA:INFE	France	€182.41 Million
SRP Groupe SA PA:SRP	France	€240.20 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Ilyang Pharmaceutical Co.,Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Ilyang Pharmaceutical Co.,Ltd total assets.

Liquidity & Leverage Metrics

Ilyang Pharmaceutical Co.,Ltd Total Liabilities Ratios Explained

Ilyang Pharmaceutical Co.,Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.77	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilyang Pharmaceutical Co.,Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilyang Pharmaceutical Co.,Ltd (2014–2025)

The table below shows the annual total liabilities of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩215.92 Billion ≈ $146.33 Million	+12.76%
2024-12-31	₩191.49 Billion ≈ $129.77 Million	+19.49%
2023-12-31	₩160.25 Billion ≈ $108.60 Million	-22.33%
2022-12-31	₩206.33 Billion ≈ $139.83 Million	-7.27%
2021-12-31	₩222.51 Billion ≈ $150.79 Million	+14.58%
2020-12-31	₩194.19 Billion ≈ $131.60 Million	-9.56%
2019-12-31	₩214.72 Billion ≈ $145.51 Million	-3.44%
2018-12-31	₩222.37 Billion ≈ $150.70 Million	-1.34%
2017-12-31	₩225.39 Billion ≈ $152.74 Million	+5.37%
2016-12-31	₩213.91 Billion ≈ $144.96 Million	-3.04%
2015-12-31	₩220.62 Billion ≈ $149.51 Million	-10.81%
2014-12-31	₩247.37 Billion ≈ $167.64 Million	--

About Ilyang Pharmaceutical Co.,Ltd

KO:007575 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$83.96 Million

₩123.89 Billion KRW

Market Cap Rank

#19654 Global

#998 in Korea

Share Price

₩6820.00

Change (1 day)

-0.15%

52-Week Range

₩6820.00 - ₩8380.00

All Time High

₩141909.13